Metzger Michael A sold SNDX
July 16, 2025 · Form 4 insider transaction
Metzger Michael A sold 7,534 shares of Syndax Pharmaceuticals, Inc. at $9.29 per share, a transaction worth $70.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,534
Price
$9.29
Total value
$70.0K
InsiderMetzger Michael A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 16, 2025
Filing dateJuly 18, 2025
Shares owned after298,661
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.